News
Being the boss of Betsi Cadwaladr, small boats, crumbling infrastructure, jury-free trials and Plaid Cymru at 100 ...
The phase III clinical trial enrolment for India's first one-shot dengue vaccine, DengiAll, developed by Panacea Biotec, is set to complete with 10,500 participants across 20 centers. This trial aims ...
Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...
Medically accredited supplement gains national traction with expert-backed multi-action formula and user trust.
Just a week before clinical trials were set to begin, South African scientists working on a promising HIV vaccine were told to halt all work, as the Trump administration abruptly withdrew $46 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results